Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
Abstract
OBJECTIVE
The purpose of this study was to improve peroral bioavailability of the very poorly water-soluble hepatoprotectant silymarin
through formation of semisolid dispersion (SD) system with Gelucire 44/14.
METHOD
Binary SD systems were prepared by the solvent-fusion method and confirmed by differential scanning calorimetry (DSC). The
solubility and in vitro release at pH values of 1.2 and 7.4 were then determined. The pharmacokinetic parameters and relative
bioavailability of orally administrated silymarin pure (SP), silymarin-Gelucire 44/14 SD (GL) capsules were assessed and compared
to that of Hepaticum (silybin-cyclodextrin) capsules (CP) as a reference standard (RF) using New Zealand albino rabbits.
RESULTS
A linear increase in solubility of silymarin with respect to the weight fraction of the carrier has been observed.
RESULTS
The solubility of silymarin SD increased - 1.5-to-7-fold (relative to pure silymarin) at 1-to-15% of Gelucire 44/14 which
in turn dramatically increased the dissolution rate of silymarin-Gelucire SD (91% within 10 min). The DSC study showed complete
disappearance of the silymarin endothermic peak confirming formation of silymarin SD. In the bioavailability study, SD of
silymarin with Gelucire 44/14 profoundly increased the AUC(0-12) and C(max) values (-13-fold relative to RS).
CONCLUSION
The solubility and dissolution pattern of silymarin were found to be carrier ratio dependent. Moreover, the in vitro solubility
and dissolution data established very good correlation with the calculated in vivo pharmacokinetic parameters. The ratios
between the mean AUC(0-12) for GL capsules and that of CP capsules was significantly higher (156.2%). However, the Tmax values
of the three formulations remained eventually unchanged.
Links
Authors
Hussein A, El-Menshawe S, Afouna M
Institution
Department of Pharmaceutics, Minia University, Minia, Egypt.
Source
Die Pharmazie 67:3 2012 Mar pg 209-14MeSH
AnimalsArea Under Curve
Biological Availability
Calorimetry, Differential Scanning
Capsules
Chemistry, Pharmaceutical
Drug Carriers
Excipients
Gelatin
Half-Life
Hydrogen-Ion Concentration
Male
Polyethylene Glycols
Protective Agents
Rabbits
Silymarin
Solubility
Temperature
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22530301
Log In

